Ji Research Group In The Division of Oncology

Technologies

We are developing novel DNA sequencing technologies to facilitate the analysis of cancer genomes for clinically relevant cancer mutations and other genetic variations. We are also applying these systems towards analysis of Mendelian cancer families. Parallel to these efforts are technology development projects to improve clinical genome sequencing and determination of genetic variation from viral infections.

Footer Links: